Green Cross Pharmaceuticals,·Venture Capital, Invest $12 million in AI Healthcare

  • 2018. 11. 26

VUNO has received $12 million in Series B funding.  In this round, 4 venture capital funds and Korea's largest

pharmaceutical company participated.   

Previous investor Smilegate Investments, SBI investments, HB Investments, Future Play participated in this round. 

Green Cross Pharmaceuticals participated as a new strategic investor.  Collectively, the investors participated

in a round of $12 million dollars in a redeemable convertible preference shares (RCPS) format.